Bharat Tewarie, MD, MBA
- CEO, Helio Genomics
- Chair, New England Chapter; Chair, Advisory Committee
Dr. Bharat Tewarie is the CEO of Helio Genomics , a commercial precision oncology company using an AI platform to detect cancer earlier when patients have the best chance for improved outcomes.
After his training as medical doctor (MD) with an MBA, he has held roles with increasing executive responsibilities in Europe and USA at multinational BioPharma companies such as Boehringer Ingelheim, Roche, Serono International, EMD Serono, Merck Serono, UCB and several emerging biotech & digital health companies.
From 2015-2019, Bharat worked as the Executive Vice President & Chief Marketing Officer and member of the Executive Committee of UCB, Brussels, Belgium. In January 2020, he founded Boston BioPharma Consultants advising executives of BioPharma and medical device companies about commercial topics. In June 2021 he joined Aveta Biomics as an independent member of the Board of Directors .
From 2020 onwards, Dr. Tewarie has been mentoring CEOs and Founders of Biotech and Digital Tech companies at the Endless Frontiers Lab Program at New York University’s Stern School of Business.
Bharat has chaired the NAF New England Chapter Committee since January 2023 and was elected on the NAF Board of Directors in 2024. He also chairs the NAF Advisory Committee, and serves on the NAF Fundraising Committee and Executive Committee.
Bharat lived and worked in The Netherlands, Germany, Switzerland and Belgium and moved to the US in 2003. He currently lives with his wife Renu in Massachusetts, USA and travels regularly back to the Netherlands to see family and friends.
